{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:41:35Z","timestamp":1790948495746,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A total of 142 patients with myeloproliferative neoplasms (MPNs) or acute myeloid leukemia (AML) associated with multihit <jats:italic>TP53<\/jats:italic> mutations (m<jats:italic>TP53<\/jats:italic>\n<jats:sup>MUT<\/jats:sup>) were accessed from the Mayo Clinic database and included (i) chronic phase MPN (MPN\u2010CP; <jats:italic>N<\/jats:italic>\u2009=\u200919), (ii) accelerated phase MPN (MPN\u2010AP; <jats:italic>N<\/jats:italic>\u2009=\u200914), (iii) blast phase MPN (MPN\u2010BP; <jats:italic>N<\/jats:italic>\u2009=\u200928), and (iv) AML (<jats:italic>N<\/jats:italic>\u2009=\u200981). Concurrent <jats:italic>ASXL1<\/jats:italic>\n<jats:sup>MUT<\/jats:sup>, <jats:italic>EZH2<\/jats:italic>\n<jats:sup>MUT<\/jats:sup>, <jats:italic>IDH1<\/jats:italic>,<jats:sup>MUT<\/jats:sup> and <jats:italic>IDH2<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> were more common in MPN\u2010<jats:sup>MUT<\/jats:sup>BP\u2010mTP53 compared to AML\u2010m<jats:italic>TP53<\/jats:italic>\n<jats:sup>MUT<\/jats:sup>. At median of 11.6\u2009months follow\u2010up, 124 (87%) deaths and 19 (13%) allogeneic stem cell transplantations (ASCT) were documented. Overall survival (OS), calculated from the time of m<jats:italic>TP53<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> detection, was similar between MPN\u2010BP\u2010m<jats:italic>TP53<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> (median 4.6\u2009months) and MPN\u2010AP\u2010m<jats:italic>TP53<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> (5.6\u2009months; <jats:italic>p<\/jats:italic>\u2009=\u20090.5) but both were inferior to MPN\u2010CP\u2010m<jats:italic>TP53<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> (11.6\u2009months, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). OS in MPN\u2010CP\u2010m<jats:italic>TP53<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> was similar to that of AML\u2010m<jats:italic>TP53<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> (median 7.4\u2009months, <jats:italic>p<\/jats:italic>\u2009=\u20090.07). In multivariable analysis, OS was favorably affected by ASCT (HR 0.4, <jats:italic>p<\/jats:italic>\u2009=\u20090.03) and disease stage (i.e., chronic phase disease) or achieving response to pre\u2010transplant chemotherapy (HR 0.2, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) and unfavorably by the presence of concurrent <jats:italic>TET2<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> or <jats:italic>DNMT3A<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> (HR 2.7, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Based on these risk factors, a 3\u2010tiered risk model was constructed: low (no risk factors; <jats:italic>N<\/jats:italic>\u2009=\u200918; median OS 23.8\u2009months); intermediate (one risk factor; <jats:italic>N<\/jats:italic>\u2009=\u200944; 11.1\u2009months); and high (two or more risk factors; <jats:italic>N<\/jats:italic>\u2009=\u200980; 4\u2009months; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). The current study highlights the equally detrimental impact of m<jats:italic>TP53<\/jats:italic>\n<jats:sup>MUT<\/jats:sup> on long\u2010term survival in MPN and AML and identifies predictors of short\u2010term survival.<\/jats:p>","DOI":"10.1002\/ajh.27670","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:53:17Z","timestamp":1741845197000},"page":"1010-1018","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multihit <scp><i>TP53<\/i><\/scp> Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases"],"prefix":"10.1002","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-7923","authenticated-orcid":false,"given":"Saubia","family":"Fathima","sequence":"first","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maymona","family":"Abdelmagid","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alsugair","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-8593","authenticated-orcid":false,"given":"Kebede H.","family":"Begna","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-3715","authenticated-orcid":false,"given":"Aref","family":"Al\u2010Kali","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-9887","authenticated-orcid":false,"given":"Abhishek A.","family":"Mangaonkar","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9084-4148","authenticated-orcid":false,"given":"Animesh D.","family":"Pardanani","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-662X","authenticated-orcid":false,"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0434-4965","authenticated-orcid":false,"given":"Cinthya J.","family":"Zepeda Mendoza","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-8163","authenticated-orcid":false,"given":"Rong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaaren K.","family":"Reichard","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-918X","authenticated-orcid":false,"given":"Talha","family":"Badar","sequence":"additional","affiliation":[{"name":"Mayo Clinic  Jacksonville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Foran","sequence":"additional","affiliation":[{"name":"Mayo Clinic  Jacksonville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Palmer","sequence":"additional","affiliation":[{"name":"Mayo Clinic  Scottsdale ARZ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-1206","authenticated-orcid":false,"given":"Giuseppe G.","family":"Loscocco","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"},{"name":"CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms University of Florence, AOU Careggi  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Guglielmelli","sequence":"additional","affiliation":[{"name":"CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms University of Florence, AOU Careggi  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5755-0730","authenticated-orcid":false,"given":"Alessandro M.","family":"Vannucchi","sequence":"additional","affiliation":[{"name":"CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms University of Florence, AOU Careggi  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-7013","authenticated-orcid":false,"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[{"name":"Department of Pathology Texas Tech University Health Sciences Center  El Paso Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2160-9689","authenticated-orcid":false,"given":"Daniel A.","family":"Arber","sequence":"additional","affiliation":[{"name":"University of Chicago  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6666-3056","authenticated-orcid":false,"given":"Devendra","family":"Hiwase","sequence":"additional","affiliation":[{"name":"Department of Hematology Royal Adelaide Hospital and South Australian Health and Medical Research Institute  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5359-336X","authenticated-orcid":false,"given":"Mithun V.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-6172","authenticated-orcid":false,"given":"Naseema","family":"Gangat","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-3821","authenticated-orcid":false,"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[{"name":"Division of Hematology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2024.2363440"},{"key":"e_1_2_10_3_1","first-page":"1152","article-title":"TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia","volume":"11","author":"Rahme R.","year":"2023","journal-title":"Biomedicine"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2023.43.5.503"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01367-w"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014472"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018236"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010183010"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"e_1_2_10_11_1","first-page":"2024","article-title":"Are TP53 Mutations all Alike?","volume":"6","author":"Wong T. N.","year":"2024","journal-title":"Hematology"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010210251"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27609"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27564"},{"key":"e_1_2_10_15_1","volume-title":"ISCN: An International System for Human Cytogenetic Nomenclature","author":"Shaffer L. G. T. N.","year":"2005"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_432650"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2763"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(03)00003-6"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01186-5"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.263"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408\u2010023\u201000969\u20106"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.230"},{"key":"e_1_2_10_23_1","first-page":"2901","article-title":"Impact of TP53 Mutations on Outcome of Patients With Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation","volume":"141","author":"Gagelmann N.","year":"2023","journal-title":"Blood"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002727"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285000"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01077-9"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00866"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003120"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102021\u2010154151"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01737-4"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0332"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.27670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T09:49:12Z","timestamp":1754905752000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.27670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/ajh.27670"],"URL":"https:\/\/doi.org\/10.1002\/ajh.27670","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"2025-02-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}